Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsN/A

ORganoid GeneratioN Study for Cancer

Sponsor: Royal Marsden NHS Foundation Trust

NCT ID: NCT05734963

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
DNA sequencing, RNA gene expression analysis, molecular profiling (genetic)
How long the study runs
Study runs about 108 months (dates as stated)
About the drug or intervention
DNA sequencing, RNA gene expression analysis, molecular profiling — genetic: Growth of organoids from tissue samples, collection of tissue, blood and saliva samples for DNA sequencing, RNA gene expression analysis, molecular profiling
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
18 Years and over
Who
All
Number of participants
100
Started
2022-04-04
Last checked
2024-08

Plain English Summary

What is this study?

  • • Testing a new treatment for cancer
  • • Clinical study - 100 participants
  • • ORIGINS - a multi-site sample collection study to establish patient-derived pre-clinical models for cancers

Who can take part?

  • • Ages 18 Years and over
  • • Diagnosed with cancer

Where?

  • • London - The Royal Marsden Hospital

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

ORIGINS - a multi-site sample collection study to establish patient-derived pre-clinical models for cancers

More detail

People who develop cancer can often be cured if they are suitable for surgery or radiotherapy. However, a proportion of these cancers return, at which point the available treatment options are often not very effective. Our understanding of the biology of many cancers is limited, and we don't understand why some cancers are cured by surgery or radiotherapy and some are not. A better understanding of the biology of cancers could help develop new treatments, or improvements to current treatments, and this might increase the number of patients who can be cured of their disease. One way to improve the understanding we have of the biology is to look in detail at cancer samples taken from the from patients. The problem with this is that often samples are small, and the tumour tissue sample itself already dead once removed from where it was growing, which can limit the analyses that are possible. A potential solution for this is to take cancer tissue from patients and try to directly grow the cells in the laboratory. Keeping the cancer cells alive in the laboratory can be difficult but has been shown to be possible in a number of different types of cancer. This kind of model is sometimes known as an "organoid". If successfully established, it means more tests can be done to find out how the cancer is working. This study is looking at collecting samples of a person's cancer to see if we can develop these models from patients being treated for different cancers. We will ask people who are having surgery for cancer whether we can take samples from their tumour to try and achieve this. Some additional blood tests will be taken alongside the usual blood tests before and after surgery, without an additional blood draw, and before and again after any adjuvant therapy is completed. A collection of saliva will also be requested at these times and we will ask people whether they are happy for us to collect any previous tissue samples, or nay that are subsequently collected when they are being followed up, to allow comparison with the samples collected as part of this study. The main goal of this study is to see if organoids can be established in our laboratories. If these models are successfully established, we will compare them to the original tumour to check they are a good match biologically. After this we can use them to understand how the cancer works and try out new treatments.

Cancer

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓Age 18 years or older
  • ✓Patients with histologically proven or suspected cancer undergoing an interventional procedure, such as surgery or...
  • ✓Ability to give agreement to take part for biological sample collection

Who cannot take part

  • ✗Unable to undergo sample collection
  • ✗Pregnancy
See the full criteria
Inclusion Criteria: * Age 18 years or older * Patients with histologically proven or suspected cancer undergoing an interventional procedure, such as surgery or biopsy * Ability to give informed consent for biological sample collection Exclusion Criteria: * Unable to undergo sample collection * Pregnancy

Where Is This Study? (1 UK site)

The Royal Marsden Hospital

London, United Kingdom

Recruiting
Site contact (verified)

How to Get in Touch

Ben O'Leary

Sponsor contact

CONTACT

02071535337 ben.oleary@icr.ac.uk

Sarah Burton

Sponsor contact

CONTACT

origins@rmh.nhs.uk
Data sourced from ClinicalTrials.gov · Last verified: 2024-08